Blue Ridge Capital
8
16M
7
0.30
1
0.12
2
- Areas of investment
Summary
Blue Ridge Capital is the famous VC, which was founded in 1996. The main department of described VC is located in the Atlanta. The company was established in North America in United States.
The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the Blue Ridge Capital, startups are often financed by NGN Capital, Forbion Capital Partners, Arcus Ventures. The meaningful sponsors for the fund in investment in the same round are NGN Capital, Forbion Capital Partners, Arcus Ventures. In the next rounds fund is usually obtained by btov Partners, Tiger Infrastructure Partners, NGN Capital.
The fund is generally included in less than 2 deals every year. The high activity for fund was in 2000. Speaking about the real fund results, this VC is 6 percentage points less often commits exit comparing to other organizations. The increased amount of exits for fund were in 2018. Opposing the other organizations, this Blue Ridge Capital works on 0 percentage points less the average amount of lead investments. The common things for fund are deals in the range of 10 - 50 millions dollars.
The fund was created by John Griffin.
The fund has no exact preference in some founders of portfolio startups. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. We can highlight the next thriving fund investment areas, such as Biotechnology, Travel. Among the various public portfolio startups of the fund, we may underline Global Commerce Systems, Exosome Diagnostics, eLong.com
Investments analytics
Analytics
- Total investments
- 8
- Lead investments
- 1
- Exits
- 2
- Rounds per year
- 0.30
- Follow on index
- 0.12
- Investments by industry
- Health Care (3)
- E-Commerce (2)
- Biotechnology (2)
- Health Diagnostics (2)
- Genetics (2) Show 15 more
- Investments by region
-
- United States (6)
- China (2)
- Peak activity year
- 2000
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 13
- Group Appearance index
- 0.88
- Avg. company exit year
- 10
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Exosome Diagnostics | 07 Jan 2016 | Biotechnology, Health Care, Health Diagnostics, Genetics | Early Stage Venture | 16M | United States, New York, New York |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.